Aarti Pharmalabs faces ₹59.5 crore stamp duty penalty over demerger
- Aarti Pharmalabs received a ₹59.50 crore penalty order from Gujarat Stamp Authority
- The levy includes ₹25 crore in stamp duty and ₹34.50 crore in penalties
- The dispute concerns stamp duty on the 2022 demerger scheme with Aarti Industries
- The company plans to challenge the order citing strong legal grounds

*this image is generated using AI for illustrative purposes only.
Aarti Pharmalabs has received a penalty order of ₹59.50 crore from the Gujarat Stamp Authority regarding unpaid stamp duty on its demerger scheme. The company intends to challenge the decision.
The Office of the Superintendent of Stamps, Gandhinagar, issued the order on August 29, 2026, under Chapter IV of the Gujarat Stamp Act, 1958. It pertains to the Scheme of Arrangement between Aarti Industries Limited and Aarti Pharmalabs Limited, which was sanctioned by the NCLT, Ahmedabad Bench, on September 21, 2022.
Penalty Breakdown
The total liability comprises stamp duty and penalties levied for alleged short payment or non-payment of duty. The components are detailed below:
| Component | Amount |
|---|---|
| Stamp Duty | ₹25 crore |
| Penalty (deficient duty) | ₹25 crore |
| Additional Penalty | ₹9.50 crore |
| Total | ₹59.50 crore |
The stamp duty was calculated under Article 20(D) of Schedule-I of the Gujarat Stamp Act. The first penalty component equals the deficient duty amount as per Rule 9 of the Mumbai Stamp (Market Value Determination) Rules, 1984. The additional penalty was imposed under the Gujarat Stamp Act, 1958.
Company Response
Aarti Pharmalabs disclosed the receipt of the order on September 1, 2026, while awaiting the physical copy dispatched via registered post. The company stated it is evaluating the order and believes it has a strong case on merits.
Management indicated it will challenge the order, citing adequate factual and legal grounds to substantiate its position. The disclosure was made pursuant to Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.
Historical Stock Returns for Aarti Pharma Labs
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.24% | +3.87% | +29.99% | +19.84% | +0.76% | 0.0% |
How might the legal challenge against the ₹59.50 crore penalty impact Aarti Pharmalabs' short-term cash flow and liquidity ratios?
Could this dispute with the Gujarat Stamp Authority set a precedent for other companies involved in similar demerger schemes under the Gujarat Stamp Act?
What is the potential timeline for the resolution of this case, and how might prolonged litigation affect investor sentiment and stock volatility?


































